• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MGZ
Click for more information
0.00% 2.0¢

MEDIGARD LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MGZ
Is this the end ofMGZ 		17/03/19 6 1.5K
17/03/19 Last post  Ozzybear Comments Created with Sketch.  6  Views Created with Sketch.  1.5K 
MGZ
Ann: Suspension of Trading update 		15/03/19 0 249
15/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  249 
MGZ
Ann: Suspension from Official Quotation 		08/03/19 0 213
08/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  213 
MGZ
Ann: Half Yearly Report and Accounts 		27/02/19 0 121
27/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  121 
MGZ
Ann: License Agreement with Kunovus Pty Ltd 		27/02/19 30 4.2K
27/02/19 Last post  Sector Comments Created with Sketch.  30  Views Created with Sketch.  4.2K 
MGZ
Ann: Appendix 4C - quarterly 		31/01/19 0 105
31/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  105 
MGZ
News: MGZ Medigard Says Company Envisages Raising Capital In Near Term 		11/12/18 0 170
11/12/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  170 
MGZ
Ann: Medigard KT009 project and funding strategy 		11/12/18 0 190
11/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  190 

See All Discussions arrow Created with Sketch.

Top Stories

HotCopper Highlights: Your most watched stocks for Week 46, 2024

What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.